InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by ROYSTON IVOR, Chairman & CEO. Officer active across 2 companies, notably Viracta Therapeutics, Inc.. Cumulatively, 8 reports have been logged. Split: 2 buys · 0 sell. Total volume traded: €78k. History available since 15 November 2021. The latest transaction was filed on 25 May 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations8 total
25,219 shares0Common StockSEC:0001209191-22-032673:0
25,219 shares0Common StockSEC:0001209191-22-014442:0
7,000 shares@ US$0.9012.5% of flowCommon StockSEC:0001209191-21-071641:0
7,000 shares@ US$0.9012.5% of flowCommon StockSEC:0001209191-21-071641
50,437 shares0Common StockSEC:0001209191-21-067044
50,437 shares0Common StockSEC:0001209191-21-067044:0
8,000 shares@ US$5.5687.5% of flowCommon StockSEC:0001209191-21-064540
Ideal exit: 12 Aug 2022 (T+270)
8,000 shares@ US$5.5687.5% of flowCommon StockSEC:0001209191-21-064540:0
Ideal exit: 12 Aug 2022 (T+270)
8 of 8 declarations
About ROYSTON IVOR
Ivor Royston is the Chief Executive Officer of Viracta Therapeutics, Inc. He leads the company focused on developing innovative therapies for cancer treatment. His role is crucial in guiding research and the development of new treatments.
